Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data
Authors
Keywords
Biliary tract cancer, Cisplatin, Gemcitabine, Oxaliplatin, Second-line chemotherapy
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 34, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-12-23
DOI
10.1186/s13046-015-0267-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
- (2015) J. S. Chen et al. ANNALS OF ONCOLOGY
- Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues Oncologues
- (2015) Bertrand Brieau et al. CANCER
- Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma
- (2015) S. Cereda et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Metabolic reprogramming: the emerging concept and associated therapeutic strategies
- (2015) Go J. Yoshida JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Second-line chemotherapy in advanced biliary cancer: the present now will later be past
- (2014) C. Vivaldi et al. ANNALS OF ONCOLOGY
- Second-line chemotherapy in advanced biliary cancer: a systematic review
- (2014) A. Lamarca et al. ANNALS OF ONCOLOGY
- Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy
- (2014) Frédéric Fiteni et al. BMC GASTROENTEROLOGY
- Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer
- (2014) L Fornaro et al. BRITISH JOURNAL OF CANCER
- Screening for theFIG-ROS1fusion in biliary tract carcinomas by nested PCR
- (2014) Caterina Peraldo Neia et al. GENES CHROMOSOMES & CANCER
- Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway
- (2014) Shengqiang Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma
- (2014) Mitesh J. Borad et al. PLoS Genetics
- Second-line therapy in advanced biliary tract cancer: What should be the standard?
- (2013) Stefano Cereda et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma
- (2013) Yasuhito Arai et al. HEPATOLOGY
- A phase II FOLFOX-4 regimen as second-line treatment in advanced biliary tract cancer refractory to gemcitabine/cisplatin
- (2013) Shengli He et al. JOURNAL OF CHEMOTHERAPY
- Outcome of second-line chemotherapy for biliary tract cancer
- (2012) John Bridgewater et al. EUROPEAN JOURNAL OF CANCER
- Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract
- (2012) George Miller et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
- (2010) T Okusaka et al. BRITISH JOURNAL OF CANCER
- Best Supportive Care Compared With Chemotherapy for Unresectable Gall Bladder Cancer: A Randomized Controlled Study
- (2010) Atul Sharma et al. JOURNAL OF CLINICAL ONCOLOGY
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Capecitabine and Celecoxib as Second-Line Treatment of Advanced Pancreatic and Biliary Tract Cancers
- (2009) Maria S. Pino et al. ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More